COVID-19 has disrupted employee routines, placing those with serious medical conditions such as diabetes and metabolic syndrome at risk. After 10 years of research and 5 published RCTs, DayTwo offers patients an effective method to treat these illnesses by using a gut microbiome profile to match the right foods to the right patient.

Using these methods, the Huntsville Hospital System was able to achieve A1C reduction, improvement in blood sugar “time-in-range,” weight loss, and cost reduction at a time when budgets are under pressure. 

Join this webcast to explore:

• How DayTwo enabled remission for type 2 diabetes using food as medicine
• An overview of the science, including a clinical trial at the Mayo Clinic, published in JAMA, that proved people respond differently to the same food
• How DayTwo’s solution works, including how gut microbiome profiling creates food prescriptions to control blood sugar

Who Should Attend: This webcast is geared towards HR Benefits and Total Rewards Executives, Carrier Benefits and Clinical Staff, and Benefits/Compensation Consultants